TVGN Stock Analysis: Buy, Sell, or Hold?
TVGN - Tevogen Bio Holdings Inc. Common Stock
$7.00
-0.02 (-0.28%)
▼
5d:
+25.22%
30d:
+19.45%
90d:
-5.53%
HOLD
MODERATE Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 18, 2026
13d
Get Alerted When TVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TVGN is 9.4% above its trading range ($6.40). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TVGN is 9.4% above its trading range ($6.40). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: TVGN is currently trading at $7.00, which is considered extended relative to its 30-day fair value range of $4.50 to $6.40.
Technical Outlook: Technically, TVGN is showing sideways momentum. Immediate support is located at $3.82, while resistance sits at $7.42.
Market Sentiment: TVGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TVGN is showing sideways momentum. Immediate support is located at $3.82, while resistance sits at $7.42.
Market Sentiment: TVGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.50 -
$6.40
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price extended above range (+9.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 71.5% above Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$4.50 -
$6.40
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.82
Resistance Level
$7.42
Current Trend
Sideways
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$2.00
(-71.5%)
Share & Embed Analysis
Last updated: August 04, 2026 5:49 PM ET
Data refreshes hourly during market hours. Next update: 6:49 PM
Data refreshes hourly during market hours. Next update: 6:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Neal Flomenberg
SELL
501 shares
2026-03-13
Neal Flomenberg
SELL
452 shares
2026-03-11
Neal Flomenberg
SELL
19 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 42 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 48 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
